Velpanat is an Indian counterpart to Generic Epclusa from NATCO, used to treat hepatitis C. The medicine contains two active ingredients: sofosbuvir (Sofosbuvir) and velpatasvir (Velpatasvir). The manufacturer is located in India and is one of the most famous pharmaceutical giants. The company conducts extensive activities both within its own country and abroad. The huge trading and manufacturing turnover of the pharmaceutical giant Natco allows you to set minimum prices for medicines and make them affordable for all buyers. Preservation of essential medical substances in the right and verified proportions (400 mg of sofosbuvir and 100 mg of velpatasvir) is a guarantee of maximum productivity and effectiveness of the generic. You can be sure - Velpanat will cure any hepatitis C genotype, including one complicated by cirrhosis. The Epclusa Cost is roughly $78,078 for a 12-week course of treatment. Your cost might vary based on insurance or manufacturer-provided discounts. Generic Epclusa cost in India (sofosbuvir and velpatasvir) was the first direct-acting oral antiviral agent approved to treat all six major forms of hepatitis C virus (HCV).